Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

novo cover image
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, Other Oct 30 | 2020Novo to use PRV for Sema Obesity; Ph1 Glucose-responsive Insulin Trial Initiated; Novo Q3 '20 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring Oct 28 | 2020Teladoc and Livongo Q3 '20 Earnings UpdatesPurchase Blast
dexcom cover image
$599
Posted in: Glucose Monitoring, Insulin Delivery Oct 27 | 2020Dexcom G7 Reduced Wear Time; Q3 '20 Earnings UpdatePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, Glucagon, Other, SGLT2i Oct 27 | 2020Lilly, Novartis, Pfizer, and Merck Q3 '20 Earnings UpdatesPurchase Blast
novo cover image
$599
Posted in: Basal Insulin Oct 13 | 2020Two New Novo Ph1 QW Icodec TrialsPurchase Blast
european medicines agency cover image
$599
Posted in: Bolus Insulin, GLP-1RA, SGLT2i Oct 12 | 2020DAPA-HF CHMP Opinion This Week?; October 12-15 CHMP AgendaPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Oct 08 | 2020Livongo Partners with Fresenius for CKD; New CGM/AID Hospital GuidelinesPurchase Blast
1 2 3 48

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.